Avanos Medical AVNS Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Reportable segment operating income (loss) by Business | ||||||
| PM&R | $7.2M-21.7% | $9.2M+16.5% | $7.9M+17.9% | $6.7M+34.0% | $5M+85.2% | |
| Total Specialty Nutrition Systems | $84.6M+2.4% | $82.6M-5.2% | $87.1M+5.3% | $82.7M-4.4% | $86.5M+7.1% | |
| Net Sales by Product | ||||||
| Enteral feeding | $324.8M+3.2% | $314.7M+2.6% | $306.7M+3.6% | $296M+0.6% | $294.2M+1.6% | |
| Neonate solutions | $131M+10.8% | $118.2M+1.0% | $117M+4.6% | $111.9M+2.9% | $108.7M+1.9% | |
| Radiofrequency ablation | $141.8M+2.0% | $139M+2.1% | $136.2M+2.5% | $132.9M+3.3% | $128.6M+1.9% | |
| Surgical pain and recovery | $96.1M-2.7% | $98.8M-2.0% | $100.8M-2.0% | $102.9M-2.5% | $105.5M-2.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Avanos Medical break its business down?
- Avanos Medical (AVNS) reports reportable segment operating income (loss) by business across 2 parts — PM&R and Total Specialty Nutrition Systems. Each is extracted from the segment footnotes and tracked over time.
- Where does Avanos Medical's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Avanos Medical's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
